de Wied D, Bohus B, van Ree J M, Urban I
J Pharmacol Exp Ther. 1978 Mar;204(3):570-80.
Both C-terminal fragments of lipotropin (beta-LPH) (endorphins) and N-terminal fragments (e.g., ACTH 4-10) delayed extinction of pole-jumping avoidance behavior in rats. After subcutaneous injection Met5-enkephalin appeared to be as active as ACTH 4-10 whereas beta-LPH 61-69, alpha- and beta-endorphin were more potent in delaying extinction of pole-jumping avoidance behavior (approximate ED50 of alpha-endorphin 4 x 10(-11) M rat.) However, the potency of beta-LPH 61-69 and alpha-endorphin appeared to be approximately the same whereas that of beta-endorphin was less than that of ACTH 4-10 after intraventricular administration (approximate ED50 of alpha-endorphin 0.2 x 10(-11) M rat). alpha-Endorphin and ACTH 4-10, administered subcutaneously in a dose which markedly delayed extinction of pole-jumping avoidance behavior, had only slight effects on open field behavior and on responsiveness to electric footshock. A 5 times higher dose of both peptides facilitated passive avoidance behavior. Morphine in two doses significantly delayed extinction of pole-jumping avoidance behavior but the effect was not dose dependent. The specific opiate antagonist naltrexone, however, markedly facilitated extinction of the avoidance response. ACTH 4-10, alpha- and beta-endorphin and a behaviorally potent ACTH 4-9 analog (Org 2766) restored pole-jumping avoidance behavior of rats pretreated with naltrexone. Treatment with a similar dose of naltrexone blocked beta-endorphin-induced analgesia. These results suggest that the influence of peptides related to C-terminal and N-terminal fragments of lipotropin on extinction of avoidance behavior may be dissociated from those exerted on opiate receptor sites. Subcutaneously injected beta-LPH 61-69 or intraventricularly administered beta-endorphin induced a shift from lower to higher frequencies of hippocampal theta rhythm during paradoxical sleep in the same way as that found after ACTH 4-10. This effect is interpreted as indicating an increased arousal state in certain midbrain limbic structures. This may, as has been postulated for ACTH 4-10, alter the motivational value of environmental stimuli (e.g., aversive stimulation).
促脂解素(β-LPH)(内啡肽)的两个C末端片段和N末端片段(如促肾上腺皮质激素4-10)均延迟了大鼠跳杆回避行为的消退。皮下注射后,甲硫氨酸脑啡肽似乎与促肾上腺皮质激素4-10活性相当,而β-LPH 61-69、α-和β-内啡肽在延迟跳杆回避行为消退方面更有效(α-内啡肽对大鼠的半数有效剂量约为4×10⁻¹¹ M)。然而,脑室注射后,β-LPH 61-69和α-内啡肽的效力似乎大致相同,而β-内啡肽的效力低于促肾上腺皮质激素4-10(α-内啡肽对大鼠的半数有效剂量约为0.2×10⁻¹¹ M)。皮下注射能显著延迟跳杆回避行为消退剂量的α-内啡肽和促肾上腺皮质激素4-10,对旷场行为和对足部电击的反应性只有轻微影响。两种肽剂量增加5倍可促进被动回避行为。吗啡两种剂量均显著延迟跳杆回避行为的消退,但该效应不依赖剂量。然而,特异性阿片拮抗剂纳曲酮显著促进回避反应的消退。促肾上腺皮质激素4-10、α-和β-内啡肽以及一种行为活性的促肾上腺皮质激素4-9类似物(Org 2766)恢复了用纳曲酮预处理大鼠的跳杆回避行为。用类似剂量的纳曲酮处理可阻断β-内啡肽诱导的镇痛作用。这些结果表明,与促脂解素C末端和N末端片段相关的肽对回避行为消退的影响可能与对阿片受体位点的影响无关。皮下注射β-LPH 61-69或脑室注射β-内啡肽,与促肾上腺皮质激素4-10注射后一样,在异相睡眠期间诱导海马θ节律从较低频率向较高频率转变。这种效应被解释为表明某些中脑边缘结构的觉醒状态增加。这可能如对促肾上腺皮质激素4-10所假设的那样,改变环境刺激(如厌恶性刺激)的动机价值。